A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
Yngvar Fløisand, Mark A. Schroeder, Patrice Chevallier, Dominik Selleslag, Steven Devine, Anne S. Renteria, Mohamad Mohty, Ibrahim Yakoub-Agha, Chunlin Chen, Andrejus Parfionovas, Syed Quadri, Johan Jansson, Mona Akbari, Yi Bin Chen
Dive into the research topics of 'A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease'. Together they form a unique fingerprint.